Editorial: On the road to multi-modal and pluri-disciplinary treatment of glioblastomas

Acta Neurochirurgica

Volumn 151, Issue 2, 2009, Pages 109-112

  Lefranc, Florence ^a  

^a FREE UNIVERSITY OF BRUSSELS   (Belgium)

Author keywords

Multi modal; Pluri disciplinary treatment of glioblastomas

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANTINEOPLASTIC AGENT; BEVACIZUMAB; CARMUSTINE; DENDRITIC CELL VACCINE; IRINOTECAN; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; TEMOZOLOMIDE; TOXIN; TP 38; UNCLASSIFIED DRUG; ALKYLATING AGENT; DACARBAZINE; DRUG DERIVATIVE;

APOPTOSIS; AUTOPHAGY; CANCER STEM CELL; CANCER SURVIVAL; CELL MIGRATION; CELL PROLIFERATION; CONVECTION ENHANCED DELIVERY SYSTEM; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG TARGETING; GLIOBLASTOMA; HUMAN; MULTIMODALITY CANCER THERAPY; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROMOTER REGION; RECURRENT CANCER; REVIEW; TUMOR RESISTANCE; BRAIN TUMOR; CANCER INVASION; DRUG ANTAGONISM; DRUG EFFECT; DRUG RESISTANCE; EDITORIAL; GENETICS; METABOLISM; NEUROSURGERY; PATHOPHYSIOLOGY; PATIENT CARE;

ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BRAIN NEOPLASMS; DACARBAZINE; DRUG RESISTANCE; GLIOBLASTOMA; HUMANS; NEOPLASM INVASIVENESS; NEUROSURGICAL PROCEDURES; PATIENT CARE TEAM; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 65449177671     PISSN: 00016268     EISSN: 09420940     Source Type: Journal    
DOI: 10.1007/s00701-009-0185-9     Document Type: Review

References (38)

1. L Bauchet V Rigau H Mathieu-Daudé D Figarella-Branger D Hugues L Palusseau F Bauchet M Fabbro C Campello L Capelle A Durand B Trétarre D Frappaz D Henin P Menei J Honnorat F Segnarbieux 2007 French brain tumour data bank: methodology and first results on 10,000 cases J Neuro-Oncol 84 189 199 (Pubitemid 47202129)
2. 6-methylguanine-DNA methyltransferase and survival in inoperable newly diagnosed glioblastoma patients treated with neoadjuvant temozolomide J Clin Oncol 25 1470 1475 (Pubitemid 46733073)
3. S de Vleeschouwer M Rapp RV Sorg HJ Steiger W Stummer S van Gool M Sabel 2006 Dendritic cell vaccination in patients with malignant gliomas: current status and future directions Neurosurgery 59 988 999
4. D Figarella-Branger C Colin O Chinot I Nanni N Baeza F Fina S Tong N Eudes B Quilichini S Romain P Metellus S Fuentes M Barrié C Boucard C Fraslon MJ Bonavita PM Martin L Ouafik 2006 AP-HM tumour tissue bank: molecular signature of gliomas Med Sci (Paris) 22 Spec No 1 54 59 (Pubitemid 43117052)
5. RJ Gilberson JN Rich 2007 Making a tumour's bed: glioblastoma stem cells and the vascular niche Nat Rev Cancer 7 733 736 (Pubitemid 47463683)
6. T Gorlia MJ van den Bent ME Hegi RO Mirimanoff M Weller JG Cairncross E Eisenhauer K Belanger AA Brandes A Allgeier D Lacombe R Stupp 2008 Gorlia nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3 Lancet Oncol 9 29 38
7. Y Hayashi NA Edwards MA Proescholdt EH Oldfield MJ Merrill 2007 Regulation and function of aquaporin-1 in glioma cells Neoplasia 9 777 787 (Pubitemid 47523239)
8. ME Hegi AC Diserens S Godard PY Dietrich L Regli S Ostermann P Otten G Van Melle N de Tribolet R Stupp 2004 Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide Clin Cancer Res 10 1871 1874 (Pubitemid 38375541)
9. E Jouanneau D Poujol C Caux MF Belin JY Blay I Puisieux Club de Neuro-Oncologie de la Société Française de Neurochirurgie 2006 Dendritic cells and gliomas: a hope in immunotherapy? Neurochirurgie 52 555 570 (Pubitemid 46034129)
10. T Kanzawa IM Germano T Komata H Ito Y Kondo S Kondo 2004 Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells Cell Death Differ 11 448 457 (Pubitemid 38489422)
11. K Lamszus O Heese M Westphal 2004 Angiogenesis-related growth factors in brain tumours Cancer Treat Res 117 169 190
12. AB Lassman EC Holland 2007 Incorporating molecular tools into clinical trials and treatment for gliomas? Curr Opin Neurol 20 708 711 (Pubitemid 350085015)
13. F Lefranc J Brotchi R Kiss 2005 Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis J Clin Oncol 23 2411 2422 (Pubitemid 46218735)
14. F Lefranc V Facchini R Kiss 2007 Pro-autophagic drugs: a novel means to combat apoptosis-resistant cancers The Oncologist 12 1395 1403
15. F Lefranc S James I Camby JF Gaussin F Darro J Brotchi HJ Gabius R Kiss 2005 Combined cimetidine and temozolomide, compared with temozolomide alone: significant increases in survival in nude mice bearing U373 human glioblastoma multiform orthotopic xenografts J Neurosurg 102 706 714 (Pubitemid 43186676)
16. F Lefranc R Kiss 2006 Autophagy, the Trojan horse to combat glioblastomas Neurosurg Focus 20 E7
17. +-ATPase) to combat glioblastoma cells Neurosurgery 62 211 221
18. F Lefranc N Sadeghi I Camby T Metens O Dewitte R Kiss 2006 Present and potential future issues in glioblastoma treatment Expert Rev Anticancer Ther 6 719 732 (Pubitemid 44192888)
19. M Le Mercier F Lefranc O Mijatovic T Debeir B Haibe-Kains G Bontempi C Decaestecker R Kiss V Mathieu 2008 Evidence of galectin-1 involvement in glioma chemoresistance Tox Appl Pharm 229 172 183
20. M Le Mercier V Mathieu B Haibe-Kains G Bontempi T Mijatovic C Decaestecker R Kiss F Lefranc 2008 Knocking down galectin-1 in human Hs683 glioblastoma cells impairs both angiogenesis through ORP150 depletion and endoplasmic reticulum stress responses J Neuropathol Exp Neurol 67 456 469
21. SA Lyons WJ Chung AK Weaver T Oqunrinu H Sontheimer 2007 Autocrine glutamate signaling promotes glioma cell invasion Cancer Res 67 9463 9471 (Pubitemid 47535936)
22. IK Mellinghoff MY Wang I Vivanco DA Haas-Kogan S Zhu EQ Dia KV Lu K Yoshimoto JH Huang DJ Chute BL Riggs S Horvath LM Liau WK Cavenee PN Rao R Beroukhim TC Peck JC Lee WR Sellers D Stokoe M Prados TF Cloughesy CL Sawyers PS Mischel 2005 Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors N Engl J Med 353 2012 2024 (Pubitemid 41609094)
23. T Mijatovic E Van Quaquebeke B Delest O Debeir F Darro R Kiss 2007 Cardiotonic steroids on the road to anti-cancer therapy Biochim Biophys Acta 1776 32 57 (Pubitemid 47334788)
24. H Okada TW Mak 2004 Pathways of apoptotic and non-apoptotic death in tumour cells Nature Rev Cancer 4 592 603 (Pubitemid 39025054)
25. AM Omuro JY Delattre 2007 Editorial: what is new in the treatment of gliomas? Curr Opin Neurol 20 704 707 (Pubitemid 350085014)
26. AM Omuro S Faivre E Raymond 2007 Lessons learned in the development of targeted therapy for malignant gliomas Mol Cancer Ther 6 1909 1919 (Pubitemid 47052481)
27. CB Ransom JT O'Neal H Sontheimer 2001 Volume-activated chloride currents contribute to the resting conductance and invasive migration of human glioma cells J Neurosci 21 7674 7683 (Pubitemid 32904966)
28. WP Roos LF Batista SC Naumann W Wick M Weller CF Menck B Kaina 2007 Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine Oncogene 26 186 197 (Pubitemid 46095730)
29. JH Sampson G Akabani GE Archer MS Berger RE Coleman AH Friedman HS Friedman K Greer JE Herndon Ii S Kunwar RE McLendon A Paolino NA Petry JM Provenzale DA Reardon TZ Wong MR Zalutsky I Pastan DD Bigner 2008 Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumours Neuro Oncol 10 320 329
30. JH Sampson ML Brady NA Petry D Croteau AH Friedman HS Friedman T Wong DD Bigner I Pastan RK Puri C Pedain 2007 Intracerebral infusate distribution by convection-enhanced delivery in humans with malignant gliomas: descriptive effects of target anatomy and catheter positioning Neurosurgery 60 2 Suppl 1 ONS89 ONS98 (Pubitemid 46254820)
31. N Sanai A Alvarez-Buylla M Berger 2005 Neural stem cells and the origin of gliomas N Engl J Med 353 811 822
32. S Sathornsumetee DA Readon A Desjardins JA Quinn JJ Vredenburgh JN Rich 2007 Molecularly targeted therapy for malignant glioma Cancer 110 13 24 (Pubitemid 46986413)
33. V Senner S Schmidtpeter S Braune S Püttmann S Thanos U Bartsch M Schachner W Paulus 2003 AMOG/beta2 and glioma invasion: does loss of AMOG make tumour cells run amok? Neuropathol Appl Neurobiol 29 370 377 (Pubitemid 36960338)
34. LA Stewart 2002 Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials Lancet 359 1011 1018 (Pubitemid 34286538)
35. W Stummer HJ Reulen T Meinel U Pichlmeier W Schumacher JC Tonn V Rohde F Oppel B Turowski C Woiciechowsky K Franz T Pietsch ALA-Glioma Study Group 2008 Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias Neurosurgery 62 564 576
36. R Stupp WP Mason MJ van den Bent M Weller B Fisher MJ Taphoorn K Belanger AA Brandes C Marosi U Bogdahn J Curschmann RC Janzer SK Ludwin T Gorlia A Allgeier D Lacombe JG Cairncross E Eisenhauer RO Mirimanoff 2005 European Organisation for Research and Treatment of Cancer Brain Tumour and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group: radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 987 996
37. Wagner SA, Desjardins A, Reardon DA, Marcello J, Herndon JE II, Quinn JA, Rich JN, Sathornsumetee S, Friedman HS, Vredenburgh JJ (2008) Update on survival from the original phase II trial of bevacizumab and irinotecan in recurrent malignant gliomas. J Clin Oncol 26:(May 20 suppl; abstr 2021)
38. M Westphal DC Hilt E Bortey P Delavault R Olivares PC Warnke IR Whittle J Jääskeläinen Z Ram 2003 A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma Neuro Oncol 5 79 88 (Pubitemid 36422560)